Remarkably, analyses of disease-specific survival of these 86 patients revealed that none of the LIMA1 (alpha) low patients died of HNSCC during follow-up (Fig. 3D), whereas all HNSCC-related deaths during the follow-up occurred in LIMA1-positive HNSCC patients. The gene discussed is LIMA1; the disease is head and neck squamous cell carcinoma.